BCM
SCMP

Beryl Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Beryl Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-29,942
Closed -$537K – 42
2017
Q4 		$537K Buy
+29,942
New +$369K 0.3% 20

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Beryl Capital Management's SCMP Position: Q1 2018 in Review

Beryl Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 29,942 shares — an estimated $537K sold.

Beryl Capital Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $537K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Beryl Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Beryl Capital Management sold 29,942 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $537K.
  • Beryl Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Beryl Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $537K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Beryl Capital Management's 13F filing for Q1 2018, filed 15 May 2018.